Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: SHYNIANBIO INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2024-02-15 to 2025-02-14
Current total value of award: $354500
Description: PHASE I THERAPEUTIC AWARD - DEVELOPING SPLIT, CONDITIONALLY ACTIVE PEPTIDOMIMETICS OF IL-12 FOR THE TREATMENT OF RARE PEDIATRIC DIPG